<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Risk factors for failing sub-Tenon’s triamcinolone acetonide for uveitic macular edema

placeholder

Researchers from the CU Department of Ophthalmology write that sub-Tenon’s triamcinolone acetonide is an effective therapy for treating uveitic macular edema, particularly for patients with lower baseline central subfield thickness.

Topics: Press Coverage